Scotland’s NHS can now offer givinostat to ambulant children with Duchenne muscular dystrophy, marking a step forward in care ...

The addition of these two rare diseases to the RUSP is a victory for American families and the nearly 1 in 500 newborns who ...

Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced ...

Detailed price information for Dyne Therapeutics Inc (DYN-Q) from The Globe and Mail including charting and trades.

Sarepta Therapeutics (NASDAQ:SRPT) leads in genetic therapies, contributing to ongoing discussions surrounding the nasdaq ...

Hilary Swank is apologizing after being called out by a woman she saw at an airport on a Make-A-Wish trip with her kids.

Detailed price information for Jazz Pharma Plc (JAZZ-Q) from The Globe and Mail including charting and trades.

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Citius Oncology entered into an exclusive distribution agreement with Er-Kim to expand international access to Lymphir (denileukin diftitox-cxdl) in Turkey, Bahrain, Qatar, Oman, Kuwait, Saudi Arabia ...

Perimetrics, the dental technology company behind InnerView - the first and only FDA-cleared device that measures internal mobility, generally associated with cracks and loose restorations - today ...

Last 28 March 2025, the European Commission decided not to renew the conditional marketing authorisation for Translarna (ataluren) in Duchenne’s disease due to lack of efficacy after 11 years in the ...

The issuer is solely responsible for the content of this announcement.